In February, a small pharma company was poised for the Canadian launch of a drug approved to reduce the risk of cardiovascular (CV) events in high-risk patients. “All dressed up” with what seemed like ...

Infiniti Research has announced the release of its latest success story on pharma product launch strategy.

BOSTON & NEW YORK, May 22, 2024--LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma Product Launch (Non-OTC)" at this year’s PRWeek Healthcare Awards ...

This Best Practices, LLC benchmarking study identifies winning strategies, structures, and best practices in early-stage product commercialization and portfolio management.

Just 4% of pharma’s digital product launches regularly succeed, according to a recent report. “I’m not surprised that from an execution standpoint, given what people were trying to do with all this ...

With numerous companies investing in novel primary immune deficiency therapies, the pharmaceutical product launch of emerging treatments is expected to reshape the competitive landscape significantly.

Verona Pharma's Ohtuvayre launch drives rapid growth and global expansion. Read about the VRNA stock's Q1 results, analyst insights, and future rally potential.

Leading organizations have found that a one-size-fits-all approach to education can hinder a new Oncology product launch as KOLs, physicians, and payers in the Oncology area have specific needs ...

Moberg Pharma's MOB-015 has outstanding clinical trial data, 76% cure rate, double the current standard topical, Jublia. Read why MBGPF stock should be bought.

Read our case study with Menarini Stemline here. About LaVoieHealthScience LaVoieHealthScience partners with health and science emerging and commercial organizations to advance their innovations.